Leukotriene receptor antagonists enhance HCC treatment efficacy by inhibiting ADAMs and suppressing MICA shedding.
Arai J, Goto K, Otoyama Y, Nakajima Y, Sugiura I, Kajiwara A, Tojo M, Ichikawa Y, Uozumi S, Shimozuma Y, Uchikoshi M, Sakaki M, Nozawa H, Nakagawa R, Muroyama R, Kato N, Yoshida H.
Arai J, et al. Among authors: goto k.
Cancer Immunol Immunother. 2021 Jan;70(1):203-213. doi: 10.1007/s00262-020-02660-2. Epub 2020 Jul 18.
Cancer Immunol Immunother. 2021.
PMID: 32683508
Free PMC article.